Emerging medicinal use On one July, 2023, the Therapeutic Goods Administration amended its scheduling of copyright substances to enable the prescription of psilocybin for use in copyright assisted psychotherapy for treatment method-resistant despair. Trials as to their usefulness and basic safety in treating many psychiatric ailments are ongoing.W